- Filed
- Feb 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Feb 10, 2025 | 2.46M sh |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $1.13M |
| Short Term Debt | Q3 2025 · Mar 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $11.82M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $8.61M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $2.25M |
| Current Liabilities | Q3 2025 · Mar 31, 2024 | $777K |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $2.25M |
| Total Liabilities | Q3 2025 · Mar 31, 2024 | $1.78M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $11.93M |
| Current Assets | Q3 2025 · Mar 31, 2024 | $9.39M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $11.95M |
| Total Assets | Q3 2025 · Mar 31, 2024 | $9.41M |
| Capex | Q3 2025 · Dec 31, 2023 | $16K |
| Operating Cash Flow | Q3 2025 · Dec 31, 2023 | −$4.36M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$5.6M |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | −$2.92M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $2.62M |
| Stockholders Equity | Q3 2025 · Mar 31, 2023 | $644K |
| Eps Basic restated | Q3 2025 · Dec 31, 2023 | −$3.07 |
| Eps Basic restated | Q3 2025 · Dec 31, 2023 | −$10.02 |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $2.24M |
| Sga Expense restated | Q3 2025 · Dec 31, 2023 | $3.53M |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $687K |
| Rd Expense restated | Q3 2025 · Dec 31, 2023 | $1.53M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$3.11M |
| Net Income | Q3 2025 · Dec 31, 2023 | −$10.02M |
| Net Income | Q3 2025 · Sep 30, 2023 | −$6.04M |
| Net Income | Q3 2025 · Jun 30, 2023 | −$865K |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$2.92M |
| Operating Income | Q3 2025 · Dec 31, 2023 | −$9.61M |
| Revenue | Q3 2025 · Dec 31, 2023 | $0 |
| Revenue | Q3 2025 · Dec 31, 2023 | $0 |